Human Immunodeficiency Virus (HIV) initiates infection by fusing its envelope membrane with the cell membrane through a process which is triggered through interactions with the cellular receptor and coreceptor. While the mechanism of HIV fusion has been extensively studied, the point of its entry into cells remains controversial. HIV has long been thought to fuse directly with the cell plasma membrane. However, several lines of evidence suggest that endocytic entry of HIV can lead to infection and, moreover, that endocytosis could be the predominant HIV entry pathway into different cell types. This review discusses recent findings pertinent to HIV entry routes and novel approaches to pinpoint the sites of virus entry.
Introduction
Fusion between the HIV envelope membrane and the host cell membrane is a key step in viral entry that leads to the nucleocapsid release into the cytoplasm. The fusion process is triggered through sequential interactions between the HIV envelope glycoprotein (Env) and cellular receptor (CD4) and coreceptors, CCR5 or CXCR4 (Fig. 1 ). Following the formation of ternary Env-receptor-coreceptor complexes, the transmembrane gp41 subunit of Env refolds into the thermodynamically stable 6-helix bundle (6HB) structure (reviewed in [1] ). Intermediate conformations of gp41 formed en route to 6HB (referred to as pre-bundles or pre-hairpins, Fig. 1 ) transiently expose conserved functionally important gp41 epitopes. These epitopes are targeted by inhibitory peptides and neutralizing antibodies which block fusion by inhibiting the 6HB formation [1] .
While the general principles of HIV Env-mediated fusion are reasonably well understood, the virus entry pathway(s) resulting in productive infection remain controversial [1] [2] [3] [4] . The identification of productive entry pathways is confounded by the fact that most HIV particles appear to be degraded by a cell while only a minor fraction establishes infection. Another issue is that, unlike many other enveloped viruses, HIV Env-mediated membrane fusion does not usually require low pH (e.g., [5, 6] ). This shows that HIV fusion is not restricted to acidic intracellular compartments and can, therefore, occur at the cell surface or in endosomes. This review attempts to reconcile discrepant reports regarding the HIV entry route, focusing primarily on cell-free virus, which is somewhat more amenable to studies of the entry point than a cell-to-cell transmission route. Here, the term HIV entry will be used to refer to a sequence of events leading to viral fusion (and, potentially, to infection). This is in contrast to bulk virus endocytosis, which includes non-productive and productive pathways and is therefore referred to as internalization or uptake.
Traditional approaches to elucidating the point of HIV entry
Experimental approaches aimed at defining the site of HIV entry often lacked the ability to directly relate the readout (e.g., fusion or infection) to the virus entry pathway. For example, biochemical techniques, such as cellular fractionation, detect the cytosolic delivery of the viral nucleoproteins [7, 8] , but do not reveal the preceding pathways. Functional approaches to delineate the virus entry pathway(s) usually rely on disruption of endocytosis or vesicular trafficking and measuring its effect on viral fusion/infection. These interventions include: (i) raising endosomal pH [8] [9] [10] and (ii) blocking distinct endocytic pathways with specific inhibitors (when available) or by knocking down the expression or function of key proteins involved in virus uptake [11] [12] [13] [14] [15] [16] [17] . Several electron microscopy studies have captured HIV fusion events both at the plasma membrane (PM) and in endosomes of macrophages, CD4 + T cells and trophoblasts [6, 15, [18] [19] [20] . The experimental approaches outlined above also produced evidence for the existence of both entry routes, but, for the reasons discussed in the next section, endocytic entry has been viewed as a non-productive pathway.
Fusion with the plasma membrane
Direct HIV fusion with the PM has long been regarded as the only productive pathway. The following observations support this notion: (1) HIV Env is capable of mediating cell-cell fusion at neutral pH (e.g., [5] ), and HIV particles can fuse two adjacent cells, a phenomenon referred to as "fusion from without" [21] ; (2) mutations in the cytoplasmic domains of CD4 or coreceptors that impair constitutive and ligand-mediated endocytosis of these proteins do not inhibit HIV infection [22] [23] [24] ; (3) although HIV particles pseudotyped with the Vesicular Stomatitis Virus (VSV) G protein enter via endocytosis and are highly infectious, the fact that infection by these pseudoviruses no longer requires Nef and is less sensitive to mutations that alter the capsid stability [25] [26] [27] suggests distinct entry routes for HIV and VSV G pseudotypes; and (4) HIV, but not VSV G pseudoviruses, can infect resting CD4 + T cells [28, 29] (but see the next section for further discussion).
HIV Env-mediated cell signaling and actin remodeling have been implicated in multiple steps of entry, from CD4/coreceptor clustering [30] [31] [32] [33] [34] to reverse transcription [35, 36] . Since actin remodeling should help the released HIV core to penetrate the cortical actin layer [26, 36] (Fig. 3 ), the requirement for signaling and actin dynamics has been interpreted as evidence for HIV fusion with the PM [13, 34, 37] . The regulation of actin dynamics through CXCR4 signaling is particularly important for HIV infection of resting CD4 + T cells [37, 38] . In this context, the inability of VSV G pseudotypes to infect resting T cells [28, 29] has been taken as evidence against endocytic entry leading to productive infection [29] . However, signaling and actin dynamics could also be required for receptor-mediated virus endocytosis. In fact, the inability of VSV G pseudoviruses to infect resting T cells appears to stem from the lack of pseudovirus internalization in the absence of CD4 and/or coreceptor signaling [28, 39] .
Similar to cell-free viruses, the point of HIV entry upon cell-to-cell transmission is controversial. While several studies concluded that, following the formation of a virological synapse with an antigen presenting cell, HIV fuses with the PM of the uninfected cell [32, 40, 41] , others found that this transmission mode relies on virus endocytosis [42] [43] [44] [45] .
Evidence for HIV entry through endocytosis
Accumulating evidence supports productive HIV entry through endocytosis in different cell types. First, raising endosomal pH enhances HIV fusion and infection, presumably due to the reduced virus degradation in intracellular compartments [8] [9] [10] . Second, inhibition of clathrin-and dynamin-dependent endocytosis or macropinocytosis (depending on the cell type) suppresses HIV uptake, fusion and infection [11, 16, 46, 47] .
Two complementary non-invasive strategies have been recently developed to define the point of HIV entry. The first approach compares the kinetics of HIV escape from a membrane-impermeant inhibitory peptide that blocks fusion of surface-accessible virions to the kinetic of escape from low temperature that halts all fusion events (Fig. 2) . The gp41derived peptide used in these experiments inhibits HIV fusion by binding to the complementary N-terminal heptad repeat domains on gp41 pre-hairpins and interfering with the formation of 6HBs (Fig. 1 ). The two possible escape routes from the inhibitory peptide are: (i) fusion with the PM and formation of peptide-resistant 6HBs [48] and (ii) endocytosis of HIV-CD4-coreceptor complexes prior to addition of the 6HB inhibitor followed by fusion with endosomes ( Fig. 2A ). It is unlikely that HIV acquires resistance to the inhibitory peptide prior to fusing with the PM, since the requisite number of 6HBs is formed after the pore opening [48] .
Kinetic measurements revealed that HIV escaped from the inhibitory peptide earlier than from the temperature block in several cell lines of epithelial and lymphoid origin [46,47] (Fig. 2B ). The delayed resistance to low temperature compared to the membraneimpermeable 6HB inhibitor implies that a large fraction of virions enter an endocytic pathway and fuse with endosomes [46]. However, this approach does not rule out the possibility that a fraction of viruses fuses directly with the PM, especially in activated primary CD4 + T cells for which the above kinetic difference is marginal [47] .
The second experimental approach employs time-resolved imaging of single virus fusion with live cells. Here, pseudoviruses bearing HIV Env are co-labeled with a fluorescent membrane dye and a GFP-based viral content marker that is released from particles into the cytoplasm following the virus fusion ( Fig. 2A and [46] ). The loss of viral content thus marks virus-cell fusion regardless of whether this event occurs at the cell surface or in endosomes ( Fig. 2A) . The viral membrane marker also vanishes upon HIV fusion with the PM. Thus, the disappearance of the membrane marker without loss of the viral content signifies hemifusion at the cell surface. In contrast, the retention of a membrane marker following the viral content release into the cytoplasm demonstrates the virus fusion with a small subcellular compartment. Labeled pseudoviruses consistently fused with endosomes in HeLaderived and T-derived cells, as evidenced by the loss of viral content and retention of the membrane marker [46] . In contrast, almost without exception, the release of a membrane marker into the PM did not culminate in release of the viral content. Moreover, attempts to redirect the HIV fusion to the PM by slowing down the virus uptake or by accelerating the fusion process through synchronizing the post-coreceptor binding steps were not successful [47] .
Collectively, these findings indicate that HIV fusion with the PM may be disfavored for reasons that are presently not understood. It is possible that restriction factors, such as tetraspanins and syntenin-1 [49] [50] [51] [52] can interfere with HIV-PM fusion. Alternatively, endosome-associated factors may be required for efficient HIV fusion. A potential candidate for such factor is dynamin [11, 12, 46] . Measurements of the time course of HIV escape from inhibition by dynasore, a small molecule dynamin inhibitor, implicate dynamin in augmenting HIV-endosome fusion long after the virus uptake ( Fig. 2) [46]. Dynamin has also been shown to play a role in cell-to-cell transmission of HIV and Env-mediated cell-cell fusion [45, 53] .
A model for HIV entry and fusion
Current data appear to support the view that the HIV entry route depends on the cell type and their activation status (reviewed in [3] ). The site of HIV fusion can also depend on the mode of transmission (free virus vs. cell-to-cell transfer). In addition, there is evidence that different Env glycoproteins can direct the virus entry through distinct routes. Entry of some CD4-independent HIV strains appears to require low pH and endocytic machinery [10, 54, 55] . Also, the block for the HIV-2 MCR infection in non-permissive cells can be rescued by pseudotyping this virus with HIV-1 Env, by inhibiting clathrin-/dynamindependent uptake or by disrupting actin filaments [56, 57] .
To reconcile discrepant results regarding the HIV entry routes, it has been proposed that the point of entry is determined by the kinetic competition between fusion and endocytosis [3] . Thus, cells exhibiting high endocytic activity would support endosomal fusion, whereas those that slowly internalize the virus would favor fusion with the PM. Two lines of evidence argue against this model. First, a comparison of the kinetics of lipid mixing at the cell surface and content release from endosome [46] shows that ~80% of hemifusion events at the PM occurred within the first 10 min, before the onset of endosomal fusion. In other words, the initiation of HIV fusion on the cell surface of HeLa-derived cells is relatively quick, but particles hemifused at the cell surface fail to progress to full fusion. Second, fusion with the PM could not be achieved by slowing down or blocking HIV endocytosis: inhibition of dynamin impaired HIV uptake and resulted in exaggerated lipid mixing at the cell surface without allowing for detectable viral content release [47] . Therefore, at least in HeLa-derived cells the entry route appears to be independent by the rates of HIV endocytosis and fusion. These rates, however, can determine the relative efficiency of fusion/infection, since viruses that fail to engage a requisite number of CD4 and coreceptors on the cell surface prior to endocytosis should be degraded in lysosomes ( Fig. 2A) . Kinetic experiments showed that the rate of CD4 and coreceptor engagement is defined by their surface density and affinity to Env, whereas bulk virus uptake is virtually independent of the receptor expression [58] . This accounts for the lower infectivity in cells with fewer CD4 or coreceptors.
Based on the above considerations, we propose an alternative hypothesis that HIV Env glycoproteins are only capable of creating a local hemifusion or a small pore, whereas the most energy-costly pore enlargement process [59] is driven by the host cell. Indeed, Abl kinase and Wave2 signaling-mediated actin rearrangement has been implicated in promoting the conversion of HIV hemifusion to full fusion [60] . A key distinction between entry and fusion of cell-free HIV and "fusion from without" or cell-cell fusion induced by Env is that, in the latter cases, the Env-bearing membrane cannot be readily internalized by the target cell: Env is either expressed on an effector cell or on a virus wedged between adjacent cells. We therefore propose that cell-cell fusion and "fusion from without" are driven by lateral force resulting from Env-mediated signaling and actin remodeling [61] , whereas the ease with which cells internalize free HIV would minimize the potential for force generation on the cell surface. This model is supported by the observation that coverslip-immobilized HIV particles were able to fuse with the PM of overlaid target cells [62] . In addition, HIV-cell fusion and infection of susceptible cell lines are not inhibited by actin depolymerization [26, 46, 63, 64] , whereas cell-to-cell transmission [32, 63, 65] and Env-mediated cell-cell fusion [30, 61] are sensitive to actin inhibitors. Additional host factors that can help dilate the HIV fusion pore are membrane bending proteins, including dynamin ([46] and see the previous section), which could stabilize the edge of a fusion pore, as have also been suggested in [2] .
Conclusions
Endocytic HIV entry could offer advantages relative to fusion with the PM by ensuring: (i) virus delivery to the perinuclear space; (ii) protection from cytosolic restriction factors; and (iii) by shortening the cell surface exposure of gp41 intermediates targeted by 6HB inhibitors and neutralizing antibodies. The latter notion is supported by the correlation between the lifetimes of gp41 pre-bundles on the cell surface and the HIV sensitivity to gp41-derived inhibitory peptides [58, 66, 67] . However, in spite of evidence supporting the ability of HIV to enter from endosomes, the role of endocytosis in productive infection of different cell types remains to be defined.
To elucidate the HIV entry pathways, it would be helpful to reach consensus on interpreting the experimental results. Below are a few suggestions that might reconcile discrepant findings. First, the observation that HIV fuses with the PM or endosomes by electron microscopy, fluorescence microscopy or other means does not rule out the alternative pathway nor does it demonstrate productive entry. Second, the appearance of HIV p24 in the cytosolic fraction as a result of fusion does not identify the point of HIV entry. Third, HIV fusion inhibitors should not prevent virus uptake, since bulk endocytosis occurs irrespective of Env or CD4 (e.g., [8] ). (Note, however, that cell-to-cell transfer requires Env-CD4 interactions to form/maintain the virological synapse [43, 45] ). Thus, the fact that these inhibitors block infection (as they should), but not the virus uptake or cell-to-cell transmission [7, 43] could not be used as an argument for endocytic entry. Fourth, the requirement for cellular signaling and actin dynamics does not necessarily mean that HIV fuses at the cell surface. Fifth, virus co-localization with intracellular compartments in fixed cells does not constitute a proof of productive entry pathway.
It appears that the major source of conflicting reports regarding HIV entry sites is the difference in assays, which are often indirect and somewhat invasive. It is therefore critical to design and implement strategies to define the HIV entry route(s) into biologically relevant target cells. Although studies of HIV entry into primary CD4 + T cells and macrophages are challenging, it is essential to define the site(s) of fusion with these cells which differ from artificial target cells in many aspects. Toward this goal, the development of non-invasive virus labeling and single virus imaging techniques, such as real-time super-resolution fluorescence microscopy, along with well-characterized drugs and other targeted interventions, should reveal the exact sites of virus fusion. Post-fusion assays must also be developed in order to determine whether the released HIV cores establish productive infection.
Highlights

• I discuss controversial findings regarding the HIV entry sites into host cells
• There is evidence both for HIV fusion with the plasma membrane and endosomes
• New evidence highlight the role of endocytosis in productive HIV entry
• A force generation model of HIV fusion is proposed to reconcile the current results HIV Env-mediated membrane fusion and its inhibition. Key steps of HIV fusion following the engagement of CD4 and coreceptor by the gp120 subunit of Env glycoprotein are illustrated. The gp41 subunit refolds from its native conformation through a series of prebundle structures that expose conserved heptad repeat domains (shown as red and blue cylinders) into the post-fusion 6-helix bundle structure. Peptides derived from the Cterminal heptad repeat domain of gp41 (dark blue) bind to the complementary N-terminal domains (red) and prevent the formation of helical bundles. The dashed arrow between a hemifused state and the peptide-trapped intermediate is intended to show that this intermediate, and even nascent fusion pores, can be reversed in the presence of the peptides. Alternative HIV entry routes into a cell and experimental strategies to define the point of entry. (A) Sequential steps of hemifusion and fusion and redistribution of the viral membrane and content markers are illustrated for the HIV entry at the cell surface and through endocytosis. Virions that do not engage a requisite number of CD4 and coreceptors are degraded (dashed arrows). The pseudocolor transformation schemes corresponding to these pathways are shown above and on the right side of the cartoon. (B) Kinetic measurements of HIV fusion by adding a peptide inhibitor of gp41 6-helix bundles, dynamin inhibitor (dynasore) or by lowering the temperature (temperature block, TB) at indicated A model for regulation of the HIV entry sites. HIV fusion with endosomes may be augmented by cellular factors (not shown) that help enlarge the pore. Whereas fusion with the plasma membrane does not normally progress beyond hemifusion, conditions that allow for lateral force generation (red dotted arrows) by cells, in this case, virus being bound to two adjacent cells, are conducive to force generation and can thus allow virus-cell or cellcell fusion ("fusion from without"). The events that were experimentally observed by single virus imaging [46] are shown by solid black arrows and those hypothesized to occur between two cells are shown by dashed blue arrows.
